274 related articles for article (PubMed ID: 15968426)
1. [Melatonin inhibits the proliferation of pituitary prolactin-secreting tumor by suppressing the enhancer elements mutation of PRL gene in the rat].
Gao L; Yang QH; Xu RK
Sheng Li Xue Bao; 2005 Jun; 57(3):319-27. PubMed ID: 15968426
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effects of melatonin on the development of 17-beta-estradiol induced prolactinoma in relation to plasma prolactin and peroxidative lipid contents].
Gao L; Xu JP; Shan HM; Zhang R; Xu RK
Sheng Li Xue Bao; 2001 Jun; 53(3):165-9. PubMed ID: 12589398
[TBL] [Abstract][Full Text] [Related]
3. [Melatonin suppressing the proliferation of E2-induced pituitary prolactin-secreting tumor in rat involves the effects of estrogen receptor].
Yang QH; Xu JN; Zhang R; Gao L; Xu RK
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 May; 22(2):174-8. PubMed ID: 21162234
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of melatonin on the development of pituitary prolactin-producing tumors induced by 17-beta-estradiol].
Gao L; Xu RK; Pang CS; Xu JP; Shan HM; Pang SF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):49-53. PubMed ID: 12905818
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of different mutations in regulatory sequence of prolactin gene during the formation of 17 beta-estradiol-induced prolactinoma in eutopic and ectopic pituitary of rats].
Zhang FZ; Yang QH; Mao YC; Xu RK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):822-7. PubMed ID: 17260475
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of melatonin on the growth of pituitary prolactin-secreting tumor in rats.
Yang QH; Xu JN; Xu RK; Pang SF
J Pineal Res; 2006 Apr; 40(3):230-5. PubMed ID: 16499559
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro.
Yang QH; Xu JN; Xu RK; Pang SF
J Pineal Res; 2007 Mar; 42(2):172-9. PubMed ID: 17286750
[TBL] [Abstract][Full Text] [Related]
8. Pituitary prolactin-secreting tumor formation: recent developments.
Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
[TBL] [Abstract][Full Text] [Related]
9. [Experimental investigation on the etiology and pathogenesis of pituitary prolactin-secreting tumor].
Wu XM
Sheng Li Ke Xue Jin Zhan; 2000 Jan; 31(1):43-6. PubMed ID: 12532766
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliferative and pro-apoptotic effects.
Gruszka A; Pawlikowski M; Kunert-Radek J
Neuro Endocrinol Lett; 2001 Oct; 22(5):343-8. PubMed ID: 11600876
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal polypeptide antiserum affects rat prolactin mRNA in 40-day but not 110-day diethylstilbestrol-induced prolactinoma tissue.
Maas DL; Meier DA; Wahle JS; Martinson DR; Hagen TC
Mol Cell Neurosci; 1994 Apr; 5(2):182-8. PubMed ID: 8032686
[TBL] [Abstract][Full Text] [Related]
12. [Effects of growth factors and estrogen on the proliferation and prolactin gene expression in anterior pituitary cells of rats].
Wu X; Zhang R; Di A; Shan H; Xu R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):331-7. PubMed ID: 12567429
[TBL] [Abstract][Full Text] [Related]
13. [Melatonin inhibits TRH-stimulating prolactin gene expression of anterior pituitary cells in newborn rat in vitro].
Di A; Xu R; Peng S; Shan H; Qian Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Dec; 19(6):430-5. PubMed ID: 10453534
[TBL] [Abstract][Full Text] [Related]
14. A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors.
Wierinckx A; Auger C; Devauchelle P; Reynaud A; Chevallier P; Jan M; Perrin G; Fèvre-Montange M; Rey C; Figarella-Branger D; Raverot G; Belin MF; Lachuer J; Trouillas J
Endocr Relat Cancer; 2007 Sep; 14(3):887-900. PubMed ID: 17914117
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
Ma W; Ikeda H; Yoshimoto T
Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
[TBL] [Abstract][Full Text] [Related]
16. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
[TBL] [Abstract][Full Text] [Related]
17. [Expression of prolactin, TGF alpha and TGF beta 1 genes in estrogen-induced eutopic and ectopic pituitary prolactin-secreting tumors of rats].
Wu XM; Xu JP; Zhang R; Xu RK
Sheng Li Xue Bao; 1999 Dec; 51(6):675-80. PubMed ID: 11498938
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of rolipram-induced increase in the incidence of mammary adenocarcinoma: histopathological study of a 104-week oral carcinogenicity study in female Sprague-Dawley rats.
Nishiyama S; Okudaira M; Saito N
Arch Toxicol; 2006 Feb; 80(2):88-97. PubMed ID: 16167140
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
[TBL] [Abstract][Full Text] [Related]
20. Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene.
Day RN; Koike S; Sakai M; Muramatsu M; Maurer RA
Mol Endocrinol; 1990 Dec; 4(12):1964-71. PubMed ID: 2082192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
